The world population over 60 years of age will increase up to 1,2 billion people by 2025. The increased life expectancy must translate into mobility and this will require new regenerative solutions earlier in the lives of patients to ensure a healthier old age.
Orthopaedic pain should not be a lifetime sentence.
Treatments for muscoskeletal degeneration are highly specialized, costly and resources are restricted. Patients have to live with pain and loss of ability for long periods of time. Therefore Heraeus has embraced this challenge and will develop effective, safe and affordable orthobiologic solutions.